Increased Levels of Soluble CD206 Associated with Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis

<div>The longitudinal analysis of sCD206 levels and PGA VAS in 20 patients with DM, respectively. sCD20: soluble CD206; DM: dermatomyositis; VAS: visual analog scale; PGA: physician global assessment.</div>

Mediators of Inflammation

fig6

Figure 6

Figure 6: Increased Levels of Soluble CD206 Associated with Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis 